Product Information
POLYMYXIN B-TMP EYE DROPS is a generic product labeled by Bausch & Lomb Incorporated, priced at $0.4521 per ML under NDC 24208031510. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on Feb 14, 1997. Its Orange Book therapeutic-equivalence code is AT.
Strength
10000; 1 [USP'U]/mL; mg/mL
Manufacturer
Bausch & Lomb IncorporatedNDC
24208031510
Classification
Generic
Dosage Form
SOLUTION/ DROPS
Route
OPHTHALMIC
Effective Date
9/23/2026
Active Ingredients
POLYMYXIN B SULFATE; TRIMETHOPRIM SULFATEApproval Type
Generic (ANDA)
FDA Application
ANDA064120FDA Approved
2/14/1997
TE Code
AT
On Market Since
2/14/1997
Pharmacological Classes
Price Statistics
The NADAC for POLYMYXIN B-TMP EYE DROPS has been published 671 times since Nov 28, 2013, and over the history we have for it it has declined 38.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4521 per ML |
|---|---|
| All-time high | $0.8678 (Aug 13, 2014) |
| All-time low | $0.3796 (May 22, 2024) |
| 52-week high | $0.4755 |
| 52-week low | $0.4513 |
| Median price | $0.5268 |
| Average price | $0.5571 |
| Largest weekly change | -24.3% (Nov 20, 2024) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Polymyxin B Sulfate and Trimethoprim Sulfate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Bausch & Lomb Incorporated manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Polymyxin B Sulfate and Trimethoprim Sulfate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Dihydrofolate Reductase Inhibitor Antibacterial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of POLYMYXIN B-TMP EYE DROPS?
The current National Average Drug Acquisition Cost (NADAC) for POLYMYXIN B-TMP EYE DROPS, manufactured by Bausch & Lomb Incorporated, is $0.4521 per ML (NDC 24208031510), effective Sep 30, 2026.
How has the price of POLYMYXIN B-TMP EYE DROPS changed over time?
Over the history we have for it, the NADAC for POLYMYXIN B-TMP EYE DROPS has declined 38.5%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for POLYMYXIN B-TMP EYE DROPS?
Since Nov 28, 2013, the NADAC for POLYMYXIN B-TMP EYE DROPS has ranged from a low of $0.3796 (May 22, 2024) to a high of $0.8678 (Aug 13, 2014), with a median of $0.5268 per ML.
Are there cheaper alternatives to POLYMYXIN B-TMP EYE DROPS?
No other NADAC-published product currently shares the active ingredient and strength of POLYMYXIN B-TMP EYE DROPS in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures POLYMYXIN B-TMP EYE DROPS?
POLYMYXIN B-TMP EYE DROPS (NDC 24208031510) is labeled by Bausch & Lomb Incorporated, and CMS classifies it as a generic product.